Bristol-Myers Squibb and Otsuka have received an approvable letter from the Food and Drug Administration

被引：0

作者：

Anon

机构：

来源：

Chemical Market Reporter | 2002年 / 262卷 / 08期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 28 条

[1] On schizophrenia. Scientific meeting Bristol-Myers SQUIBB and OTSUKA France Pharmaceutical.
Bourin, M
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2006, 32 : 1 - 2
[2] New molecular entities/new biologics - Abilify - Aripiprazole - Bristol-Myers Squibb/Otsuka Pharmaceutical
不详
FORMULARY, 2002, 37 (12) : 608 - 608
[3] Saladex Biomedical and Bristol-Myers Squibb have entered into a further collaboration
Attwood, Claire
BIOANALYSIS, 2012, 4 (22) : 2666 - 2666
[4] Bristol-Myers Squibb acquires novel fluoroquinolone from Kyorin
不详
DRUG NEWS & PERSPECTIVES, 1996, 9 (08) : 459 - 459
[5] Parkinson's brochure series from Bristol-Myers Squibb
不详
PSYCHOPHARMAKOTHERAPIE, 2005, 12 (06): : X - X
[6] Open letter to Lamberto Andreotti, Chief Executive Officer, Bristol-Myers Squibb
Kamal-Yanni, Mohga
Nichols, Kim
Tallah, Esther
Otwoma, Nelson
LANCET, 2010, 375 (9733) : 2213 - 2213
[7] ImClone rebuffs buyout bid from Bristol-Myers Squibb
不详
CHEMICAL & ENGINEERING NEWS, 2008, 86 (32) : 21 - 21
[8] BTP buys fine chemicals unit from Bristol-Myers Squibb
不详
CHEMICAL & ENGINEERING NEWS, 1998, 76 (22) : 26 - 26
[9] Reyataz - Atazanavir - Bristol-Myers Squibb - Protease inhibitor for once-daily administration
不详
FORMULARY, 2003, 38 (08) : 455 - 455
[10] ACQUISITIONS Bristol-Myers Squibb will acquire small-molecule drug firm Amira
Jarvis, Lisa
CHEMICAL & ENGINEERING NEWS, 2011, 89 (31) : 11 - 11